- Latest available (Revised)
- Point in Time (28/03/2011)
- Original (As made)
Version Superseded: 01/04/2013
Point in time view as at 28/03/2011. This version of this provision has been superseded.
You are viewing this legislation item as it stood at a particular point in time. A later version of this or provision, including subsequent changes and effects, supersedes this version.
Note the term provision is used to describe a definable element in a piece of legislation that has legislative effect – such as a Part, Chapter or section.
There are currently no known outstanding effects for the The Misuse of Drugs Regulations 2001, Section 16.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
16.—(1) [F1Subject to paragraph (5),] a person shall not supply a controlled drug other than a drug specified in Schedule 4 or 5 on a prescription—
(a)[F2subject to paragraphs (1A) and (1C),] unless the prescription complies with the provisions of regulation 15;
(b)unless the address specified in the prescription as the address of the person issuing it is an address within the United Kingdom;
(c)unless he either is acquainted with the signature of the person by whom it purports to be issued and has no reason to suppose that it is not genuine, or has taken reasonably sufficient steps to satisfy himself that it is genuine;
(d)before the [F3appropriate date];
(e)subject to paragraph [F4(4)], later than [F5twenty-eight days] after the [F3appropriate date].
[F6(1A) A pharmacist may supply a controlled drug other than a drug specified in Schedule 4 or 5 or temazepam if the prescription contains minor typographical errors or spelling mistakes or if it does not comply with the provisions of regulation 15 in the way specified in paragraph (1B), provided that—
(a)having exercised all due diligence, he is satisfied on reasonable grounds that the prescription is genuine;
(b)having exercised all due diligence, he is satisfied on reasonable grounds that he is supplying the drug in accordance with the intention of the person issuing the prescription;
(c)he amends the prescription in ink or otherwise indelibly to correct the minor typographical errors or spelling mistakes or so that the prescription complies with the requirements of regulation 15 as the case may be; and
(d)he marks the prescription so that the amendment he has made under sub-paragraph (c) is attributable to him.
(1B) The way specified in paragraph (1A) is that, in relation to regulation 15(1)(f), the total quantity of the preparation or of the controlled drug or the number of dosage units as the case may be is specified in either words or figures but not both.
(1C) A pharmacist may supply a controlled drug other than a drug specified in Schedule 4 or 5 on a prescription other than a health prescription in a hospital if it does not comply with regulation 15 in the ways specified in paragraph (1D).
(1D) The ways specified in paragraph (1C) are—
(a)the prescription is not written on a prescription form provided by a Primary Care Trust or equivalent body for the purposes of private prescribing;
(b)the prescription does not specify the prescriber identification number of the person issuing it.]
(2) Subject to paragraphs (3) and (4), a person supplying on prescription a controlled drug other than a drug specified in Schedule 4 or 5 shall, at the time of the supply, mark on the prescription the date on which the drug is supplied and, [F7if it is a veterinary prescription,] shall retain the prescription on the premises from which the drug was supplied.
(3) A person supplying temazepam on prescription in accordance with a prescription form of a kind specified in regulation 2A(1)(a)(i) of the National Health Service (Pharmaceutical Services) Regulations 1992 shall, at the time of the supply, enter on the form by electronic means the date on which the drug is supplied.
(4) In the case of a prescription containing a controlled drug other than a drug specified in Schedule 4 or 5, which contains a direction that specified instalments of the total amount may be supplied at stated intervals, the person supplying the drug shall not do so otherwise than in accordance with that direction, and—
(a)paragraph (1) shall have effect as if for the requirement contained in sub-paragraph (e) thereof there were substituted a requirement that the occasion on which the first instalment is supplied shall not be later than [F8twenty-eight days] after the [F9appropriate date];
(b)paragraph (2) shall have effect as if for the words “at the time of the supply” there were substituted the words “ on each occasion on which an instalment is supplied ”.
[F10(5) A person shall not supply a controlled drug specified in Schedule 4 on a prescription later than twenty-eight days after the appropriate date.
(6) A person who is asked to supply on prescription a controlled drug specified in Schedule 2 must first ascertain whether the person collecting the drug is the patient, the patient’s representative or a healthcare professional acting in his professional capacity on behalf of the patient; and—
(a)where that person is the patient or the patient’s representative, he may—
(i)request evidence of that person’s identity; and
(ii)refuse to supply the drug if he is not satisfied as to the identity of that person;
(b)where that person is a healthcare professional acting in his professional capacity on behalf of the patient, he—
(i)must obtain that person’s name and address;
(ii)must, unless he is acquainted with that person, request evidence of that person’s identity; but
(iii)may supply the drug even if he is not satisfied as to the identity of that person.
(7) In this regulation—
“appropriate date” means the later of the date on which it was signed by the person issuing it or the date indicated by him as being the date before which it shall not be supplied;
“healthcare professional” has the same meaning as in the National Health Service Act 1977;
“patient” means the person named in the prescription as the person to whom the drug is to be supplied;
“patient’s representative” means a person sent by or on behalf of the patient (other than a healthcare representative acting in his professional capacity).]
Textual Amendments
F1Words in reg. 16(1) inserted (7.7.2006) by The Misuse of Drugs (Amendment No. 2) Regulations 2006 (S.I. 2006/1450), regs. 2(1), 6(1) (with regs. 12, 13)
F2Words in reg. 16(1)(a) inserted (7.7.2006) by The Misuse of Drugs (Amendment No. 2) Regulations 2006 (S.I. 2006/1450), regs. 2(1), 6(2) (with regs. 12, 13)
F3Words in reg. 16(1)(d)(e) substituted (7.7.2006) by The Misuse of Drugs (Amendment No. 2) Regulations 2006 (S.I. 2006/1450), regs. 2(1), 6(3) (with regs. 12, 13)
F4Word in reg. 16(1)(e) substituted (1.8.2003) by The Misuse of Drugs (Amendment) (No. 2) Regulations 2003 (S.I. 2003/1653), regs. 1, 2(5)
F5Words in reg. 16(1)(e) substituted (7.7.2006) by The Misuse of Drugs (Amendment No. 2) Regulations 2006 (S.I. 2006/1450), regs. 2(1), 6(4) (with regs. 12, 13)
F6Reg. 16(1A)-(1D) inserted (7.7.2006 for E.S. and for W. in so far as inserting reg. 16(1A)(1B), 1.1.2007 in so far as not already in force) by The Misuse of Drugs (Amendment No. 2) Regulations 2006 (S.I. 2006/1450), regs. 2(1)(3), 6(5) (with regs. 12, 13)
F7Words in reg. 16(2) substituted (1.9.2006) by The Misuse of Drugs (Amendment No. 3) Regulations 2006 (S.I. 2006/2178), regs. 1(1), 5
F8Words in reg. 16(4)(a) substituted (7.7.2006) by The Misuse of Drugs (Amendment No. 2) Regulations 2006 (S.I. 2006/1450), regs. 2(1), 6(4) (with regs. 12, 13)
F9Words in reg. 16(4)(a) substituted (7.7.2006) by The Misuse of Drugs (Amendment No. 2) Regulations 2006 (S.I. 2006/1450), regs. 2(1), 6(3) (with regs. 12, 13)
F10Reg. 16(5)-(7) inserted (7.7.2006) by The Misuse of Drugs (Amendment No. 2) Regulations 2006 (S.I. 2006/1450), regs. 2(1), 6(6) (with regs. 12, 13)
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: